SEC Form 4 · accession 0001127602-18-018984
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander A Santini
Officer — EVP and CCO
Period of report
May 23, 2018
Accepted (ET)
May 25, 2018 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 23, 2018 | P | 745 | $9.78 | A | 5,297 | D |
Table II — derivative securities
No Table II lines on this filing.